AMEX · Financial Statements
Oragenics Inc. (OGEN) Financial Statements
$0.46
AMEX: OGEN
Market Cap $2.06M
Overview Financials Dividend Oragenics Inc. most recently reported annual revenue of $0, net profit of $-10.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-16.0M $-14.0M $-21.0M $-11.0M $-9.0M Net Profit $-16.0M $-14.0M $-21.0M $-11.0M $-10.0M EPS $-8.09 $-7.11 $-9.18 $-1.60 $-4.56 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $28.0M $15.0M $5.0M $1.0M $10.0M Total Liabilities $2.0M $2.0M $2.0M $2.0M $2.0M Cash $27.0M $11.0M $3.0M $1.0M $4.0M Borrowings $1.0M $1.0M $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-13.0M $-15.0M $-7.0M $-9.0M $-9.2B Investing Cash Flow $0 $0 $-2.0M $0 $0 Financing Cash Flow $-5.0M $0 $0 $0 $16.8B Net Cash Flow $10.0M $-16.0M $-8.0M $-3.0M $7.5B Free Cash Flow $-14.0M $-15.0M $-8.0M $-9.0M $-9.2B
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.22 FCF Yield -452.55% Quick Ratio 3.01 Interest Coverage -561.90 Return 1Y -58.21% Return 3Y -99.50% Return 5Y -99.95%
Screens featuring this stock